{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:07:56Z","timestamp":1790032076104,"version":"4.0.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.trim.2012.05.001","type":"journal-article","created":{"date-parts":[[2012,5,15]],"date-time":"2012-05-15T00:11:35Z","timestamp":1337040695000},"page":"30-38","source":"Crossref","is-referenced-by-count":41,"title":["Immunosuppressive drugs on inducing Ag-specific CD4+CD25+Foxp3+ Treg cells during immune response in vivo"],"prefix":"10.1016","volume":"27","author":[{"given":"Tingting","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxia","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2012.05.001_bb0005","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(98)07493-5","article-title":"Immunosuppressive strategies in transplantation","volume":"353","author":"Denton","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.trim.2012.05.001_bb0010","first-page":"126","article-title":"Chronic allograft dysfunction: mechanisms and new approaches to therapy","volume":"20","author":"Womer","year":"2000","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.trim.2012.05.001_bb0015","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ni1455","article-title":"Foxp3 in control of the regulatory T cell lineage","volume":"8","author":"Zheng","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trim.2012.05.001_bb0020","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1172\/JCI200114142","article-title":"Challenges to achieving clinical transplantation tolerance","volume":"108","author":"Salama","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trim.2012.05.001_bb0025","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1111\/j.1600-6143.2008.02300.x","article-title":"New insights into mechanisms of spontaneous liver transplant tolerance: the role of Foxp3-expressing CD25+CD4+ regulatory T cells","volume":"8","author":"Li","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trim.2012.05.001_bb0030","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1586\/1744666X.3.3.245","article-title":"The different effects of cyclosporin A and rapamycin on regulatory CD4+CD25+ T cells: potential relationship with transplant tolerance induction","volume":"3","author":"Zhao","year":"2007","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.trim.2012.05.001_bb0035","doi-asserted-by":"crossref","first-page":"8060","DOI":"10.4049\/jimmunol.175.12.8060","article-title":"Elevated T regulatory cells in long-term stable transplant tolerance in rhesus macaques induced by anti-CD3 immunotoxin and deoxyspergualin","volume":"175","author":"Asiedu","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.trim.2012.05.001_bb0040","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.trim.2007.01.002","article-title":"The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice","volume":"17","author":"Qu","year":"2007","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.trim.2012.05.001_bb0045","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/01.tp.0000229473.95202.50","article-title":"Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients","volume":"82","author":"Segundo","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2012.05.001_bb0050","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1182\/blood-2004-10-3932","article-title":"Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells","volume":"105","author":"Battaglia","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.trim.2012.05.001_bb0055","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1097\/01.tp.0000246312.89689.17","article-title":"A potential side effect of cyclosporin A: inhibition of CD4(+)CD25(+) regulatory T cells in mice","volume":"82","author":"Wang","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2012.05.001_bb0060","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.4049\/jimmunol.160.11.5355","article-title":"Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines","volume":"160","author":"Blazar","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.trim.2012.05.001_bb0065","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/ndt\/gfi070","article-title":"15-Deoxyspergualin and cyclophosphamide, but not mycophenolate mofetil, prolong survival and attenuate renal disease in a murine model of ANCA-associated crescentic nephritis","volume":"21","author":"Birck","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trim.2012.05.001_bb0070","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1046\/j.1523-1755.2001.060002653.x","article-title":"Mycophenolate mofetil combined with a cyclooxygenase-2 inhibitor ameliorates murine lupus nephritis","volume":"60","author":"Zoja","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.trim.2012.05.001_bb0075","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.0300-9475.2004.01401.x","article-title":"Additive effects of leflunomide and tacrolimus in prevention of islet xenograft rejection","volume":"59","author":"Zhang","year":"2004","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.trim.2012.05.001_bb0080","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1038\/sj.jid.5700228","article-title":"Induction of regulatory T cells by leflunomide in a murine model of contact allergen sensitivity","volume":"126","author":"Weigmann","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.trim.2012.05.001_bb0085","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1002\/eji.200939330","article-title":"Homeostatic proliferation of naive CD8+ T cells depends on CD62L\/l-selectin-mediated homing to peripheral LN","volume":"39","author":"Schuster","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.trim.2012.05.001_bb0090","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.4049\/jimmunol.0901011","article-title":"The sphingosine 1-phosphate receptor agonist FTY720 potently inhibits regulatory T cell proliferation in vitro and in vivo","volume":"183","author":"Wolf","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.trim.2012.05.001_bb0095","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1158\/1078-0432.CCR-06-1209","article-title":"Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration","volume":"13","author":"Bracci","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.trim.2012.05.001_bb0100","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jaci.2005.10.042","article-title":"Cyclophosphamide augments inflammation by reducing immunosuppression in a mouse model of allergic airway disease","volume":"117","author":"Su","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trim.2012.05.001_bb0105","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00109-009-0530-8","article-title":"Induction of Foxp3 demethylation increases regulatory CD4+CD25+ T cells and prevents the occurrence of diabetes in mice","volume":"87","author":"Zheng","year":"2009","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.trim.2012.05.001_bb0110","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/15260","article-title":"Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance","volume":"5","author":"Wells","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.trim.2012.05.001_bb0115","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/jcp.21001","article-title":"The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road","volume":"211","author":"Zhang","year":"2007","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.trim.2012.05.001_bb0120","doi-asserted-by":"crossref","first-page":"e5994","DOI":"10.1371\/journal.pone.0005994","article-title":"Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin","volume":"4","author":"Strauss","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.trim.2012.05.001_bb0125","doi-asserted-by":"crossref","first-page":"320","DOI":"10.4049\/jimmunol.178.1.320","article-title":"Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin","volume":"178","author":"Strauss","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.trim.2012.05.001_bb0130","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-2249.2007.03402.x","article-title":"Daily subcutaneous injections of peptide induce CD4+ CD25+ T regulatory cells","volume":"149","author":"Dahlberg","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.trim.2012.05.001_bb0135","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2249.2008.03827.x","article-title":"Recurrent superantigen exposure in vivo leads to highly suppressive CD4+CD25+ and CD4+CD25\u2212 T cells with anergic and suppressive genetic signatures","volume":"155","author":"Schartner","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.trim.2012.05.001_bb0140","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/MOT.0b013e328306115b","article-title":"The role of positive costimulatory molecules in transplantation and tolerance","volume":"13","author":"Agarwal","year":"2008","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.trim.2012.05.001_bb0145","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/j.1600-6143.2007.01829.x","article-title":"CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects","volume":"7","author":"Kang","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trim.2012.05.001_bb0150","doi-asserted-by":"crossref","first-page":"6335","DOI":"10.1073\/pnas.0701171104","article-title":"Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment","volume":"104","author":"You","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trim.2012.05.001_bb0155","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0022-3565(25)38375-8","article-title":"Rapamycin, a potential disease-modifying antiarthritic drug","volume":"266","author":"Carlson","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.trim.2012.05.001_bb0160","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/00007890-200203270-00015","article-title":"Compared to mycophenolate mofetil, rapamycin induces significant changes on growth factors and growth factor receptors in the early days post-kidney transplantation","volume":"73","author":"Oliveira","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2012.05.001_bb0165","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/00007890-200010150-00020","article-title":"Rapamycin induces transforming growth factor-beta production by lymphocytes","volume":"70","author":"Dodge","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2012.05.001_bb0170","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1172\/JCI0211638","article-title":"Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation","volume":"109","author":"Huynh","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trim.2012.05.001_bb0175","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nri1435","article-title":"Tolerance, not immunity, crucially depends on IL-2","volume":"4","author":"Malek","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trim.2012.05.001_bb0180","doi-asserted-by":"crossref","first-page":"6519","DOI":"10.4049\/jimmunol.172.11.6519","article-title":"Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function","volume":"172","author":"Thornton","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.trim.2012.05.001_bb0185","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jaut.2006.04.005","article-title":"IL-2 receptor alpha deficiency and features of primary biliary cirrhosis","volume":"27","author":"Aoki","year":"2006","journal-title":"J Autoimmun"},{"key":"10.1016\/j.trim.2012.05.001_bb0190","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2007-06-094482","article-title":"Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells","volume":"111","author":"Zeiser","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.trim.2012.05.001_bb0195","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00262-008-0602-6","article-title":"Apoptosis of CD4(+)CD25(high) T cells in response to Sirolimus requires activation of T cell receptor and is modulated by IL-2","volume":"58","author":"Molhoek","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.trim.2012.05.001_bb0200","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.immuni.2010.11.024","article-title":"An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness","volume":"33","author":"Procaccini","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.trim.2012.05.001_bb0205","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.4049\/jimmunol.0903805","article-title":"Regulatory T cells require mammalian target of rapamycin signaling to maintain both homeostasis and alloantigen-driven proliferation in lymphocyte-replete mice","volume":"186","author":"Wang","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.trim.2012.05.001_bb0210","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/TP.0b013e3181d3c9d4","article-title":"Impact of immunosuppressants on the therapeutic efficacy of in vitro-expanded CD4+CD25+Foxp3+ regulatory T cells in allotransplantation","volume":"89","author":"Lim","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2012.05.001_bb0215","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.trim.2010.04.002","article-title":"Mycophenolate mofetil modifies kidney tubular injury and Foxp3+ regulatory T cell trafficking during recovery from experimental ischemia\u2013reperfusion","volume":"23","author":"Gandolfo","year":"2010","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.trim.2012.05.001_bb0220","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1182\/blood-2006-01-0329","article-title":"Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production","volume":"108","author":"Zeiser","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.trim.2012.05.001_bb0225","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/1568009043333014","article-title":"The role of cytochrome P450 in cytotoxic bioactivation: future therapeutic directions","volume":"4","author":"Rooney","year":"2004","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.trim.2012.05.001_bb0230","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1615\/CritRevImmunol.v28.i2.20","article-title":"Immune-potentiating effects of the chemotherapeutic drug cyclophosphamide","volume":"28","author":"Brode","year":"2008","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.trim.2012.05.001_bb0235","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00262-006-0225-8","article-title":"Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients","volume":"56","author":"Ghiringhelli","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.trim.2012.05.001_bb0240","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-2249.2007.03521.x","article-title":"Increase of CD4+ CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+ CD25+ T lymphocytes","volume":"150","author":"Audia","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.trim.2012.05.001_bb0245","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1158\/0008-5472.CAN-10-0283","article-title":"Selective depletion of CD4+CD25+Foxp3+ regulatory T cells by low-dose cyclophosphamide is explained by reduced intracellular ATP levels","volume":"70","author":"Zhao","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.trim.2012.05.001_bb0250","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/01.TP.0000164142.98167.4B","article-title":"Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FOXP3 in human T cells","volume":"80","author":"Baan","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2012.05.001_bb0255","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1182\/blood-2005-07-3032","article-title":"Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells","volume":"107","author":"Coenen","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.trim.2012.05.001_bb0260","doi-asserted-by":"crossref","unstructured":"Liu G, Yang K, Burns S, Shrestha S, Chi H. The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg) cells. Nat Immunol 11:1047\u201356.","DOI":"10.1038\/ni.1939"},{"key":"10.1016\/j.trim.2012.05.001_bb0265","doi-asserted-by":"crossref","first-page":"7797","DOI":"10.1073\/pnas.0800928105","article-title":"T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR","volume":"105","author":"Sauer","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trim.2012.05.001_bb0270","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1084\/jem.20071477","article-title":"The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells","volume":"205","author":"Haxhinasto","year":"2008","journal-title":"J Exp Med"}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096632741200038X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096632741200038X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T01:24:43Z","timestamp":1743125083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096632741200038X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S096632741200038X"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2012.05.001","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}